GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1034.20-6.55 (-0.63 %)
PREV CLOSE ( ) 1040.75
OPEN PRICE ( ) 1035.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39997
TODAY'S LOW / HIGH ( )1018.20 1043.15
52 WK LOW / HIGH ( )507.65 1068
NSE1034.50-4.85 (-0.47 %)
PREV CLOSE( ) 1039.35
OPEN PRICE ( ) 1039.35
BID PRICE (QTY) 1034.50 (5)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1223564
TODAY'S LOW / HIGH( ) 1017.50 1044.25
52 WK LOW / HIGH ( )507.4 1070
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax8684.5114412.4613824.7510960.7613006.29
Adjustment14719.637871.086448.186362.283298.35
Changes In working Capital-10744.81-5612.61-3858.381270.641363.41
Cash Flow after changes in Working Capital12659.3316670.9316414.5518593.6817668.05
Cash Flow from Operating Activities6253.9211086.5211312.1313924.1313241.71
Cash Flow from Investing Activities-5284.91-3332.80-6752.36-7835.17-6989.93
Cash Flow from Financing Activities-774.56-5204.91-4417.79-4446.63-7387.35
Net Cash Inflow / Outflow194.452548.81141.981642.33-1135.57
Opening Cash & Cash Equivalents14105.2611380.9511102.759362.7812333.56
Cash & Cash Equivalent on Amalgamation / Take over / Merger6.68NANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations123.87175.50136.2297.64-1835.21
Closing Cash & Cash Equivalent14430.2614105.2611380.9511102.759362.78

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.